Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: RT who wrote (9381)	6/8/1998 6:35:00 PM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

RT...Viagra in Brazil by way of Miami...... This would only cover the Brazilian visitors to Miami and the black market.....Viagra is not sold to the general public in Brazil....at this time...... This can help Muse for a period of time..... The recovery in the USA scripts can be used to project worldwide what percent of the ED market VVUS will be able to hold onto... In the mean time....MUSE will be ahead of Viagra in many countries... Viagra will be approved in most of these countries later...

To: RT who wrote (9381)	6/8/1998 8:30:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

RT, If you read a few of my last posts actual decline was more like 7%. I don't think the Viagra declines is necessarily good or bad for Vivus. Also, if we use a target of 14,000 total weekly MUSE scripts as complete recovery and we only see a 10% weekly increase (less than the 12.5% seen last week) then we would hit 14,241 in 9 weeks (week ending July 31st). It took us about 8 to 9 weeks to hit our lowest level and I believe it will take 8 to 9 weeks to recover. Again, I believe that international sales are the key to vivus becoming a $20.00+/share stock again. We don't need the biggest piece of the ED pie to be a serious and profitable player in the ED market.